India's Alkem Labs rises; Nomura raises PT on growth potential

Alkem Laboratories

22/08/2025 07:27

** Alkem Laboratories ALKE.NS rises 0.5% to 5,451 rupees

** Nomura retains "buy"; raises PT to 6,300 from 5,393 rupees, implying 16.2% upside to last close

** Sees recovery in domestic business, growth potential in Enzene Biosciences, Alkem's biotechnology subsidiary

** Sees growth opportunity in co's obesity drug

** Expects Enzene revenue to rise to 8 bln rupees ($91.5 mln) by FY28 vs year-ago 3.6 bln rupees

** Stock rated "hold" on avg; median PT is 5,430 rupees, per data compiled by LSEG

** YTD, ALKE falls 3.2%

($1 = 87.4300 Indian rupees)

 (Reporting by Rudra Singh)

 ((RudraPratap.Singh@thomsonreuters.com;))